CAR T Therapy Shows Similar Efficacy, Safety in Multiple Myeloma Subgroups
Cancer Network,
"Close monitoring may be warranted for patients with baseline [renal impairment] as they may experience more pronounced ICANS…
A Real-World Analysis of the Safety and Efficacy of BCMA-Directed CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment
Overview of attention for article published in Blood, November 2024
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (80th percentile)
-
Good Attention Score compared to outputs of the same age and source (68th percentile)
Readers on
- mendeley
- 1 Mendeley